The European Association for Cancer Research (EACR) announced the last Friday that Eduard Batlle is the winner of the Pezcoller Foundation – EACR Cancer Researcher Award.
The award, presented biennially to a researcher of excellence with no more than 15 years post-doctoral experience, celebrates academic excellence and achievements in the field of cancer research.
Eduard Batlle, is an ICREA (Institució Catalana de Recerca i Estudis Avançats) Research Professor at IRB Barcelona (Institut de Recerca Biomèdica) who coordinates the Oncology Programme and directs the Colorectal Cancer Laboratory Group at IRB Barcelona.
Eduard Batlle (Barcelona, 1970), received a doctorate in biology from the University of Barcelona. He spent four years at the Netherlands Institute for Developmental Biology, in Utrecht, The Netherlands, under the mentorship of the renowned scientist Hans Clevers.
His work has been published in the best biomedical journals, including several articles in Nature journals and deserving two covers in Cell and Cancer Cell. Dr. Batlle holds several prizes, including the Debiopharm Life Sciences Award for Outstanding Research in Oncology from the École Polytechnique Fédérale de Lausanne (EPFL) in Switzerland (2006), the Banc Sabadell Biomedical Research Award (2010), Dr. Josef Steiner Cancer Research Award (2013) and “Doctores Diz Pintado” National Cancer Research Prize (2014).
Research activity in the last 10 years has focused on the mechanisms that drive colorectal cancer progression. Among other findings, his work revealed the first connection between intestinal stem cells and colorectal cancer.
The inner layer of the intestinal tube, the intestinal epithelium, is in a constant process of renewal. Hundreds of millions of terminally differentiated intestinal cells are replaced by new cells every day during the life of an adult organism. This tremendous regenerative power is ultimately sustained by a small population of intestinal stem cells. It is believed that alterations in the functioning of intestinal stem cells account for the pathophysiology of various bowel disorders. Our laboratory studies the connection between the biology of Intestinal Stem Cells and Colon Cancer. We have recently archived for the first time the isolation of stem cells of the human colonic epithelium as well as of tumour stem cells from colon cancers. We are currently analysing the features of these two cell types with the aim of designing new therapeutic and diagnostic tools for the management of colon cancer.
Our most honestly congratulations